Sign-up for our newsletter
Protocols & Methods
Reagents & Resources
IMPC / KOMP Data
Washington University in St Louis
COL4A3 Variants and Susceptibility to Diabetic Nephropathy
Diabetic nephropathy (DN) is a major diabetic complication that affects a large fraction of both type I and II diabetic patients. One hallmark of DN is the dramatic thickening of the glomerular basement membrane (GBM). The GBM is an ~300 nm-thick layer of extracellular matrix composed of many different proteins, including collagen IV, laminin, nidogen, and heparan sulfate proteoglycan. It has been assumed for decades that the GBM thickening observed in diabetic nephropathy is directly related to the microalbuminuria and progression to frank proteinuria that occurs in the fraction of type I and type II diabetic patients who develop DN. Recently, Jose C. Florez of Harvard Medical School and colleagues posted the results of a high-powered genome-wide association study (GWAS) of diabetic kidney disease in type I patients. A non-synonymous variant in COL4A3 (p.Asp326Tyr) was found to protect against the development of DN. Here we propose to test the hypothesis that this COL4A3 variant results in a thinner than normal GBM in healthy mice and will reduce the extent of GBM thickening and diabetic nephropathy in type I diabetic mice. CRISPR/Cas9-mediated genome editing will be used to introduce the human alleles into the mouse Col4a3 gene in DBA/2J mice that have been shown to be susceptible to DN. Electron microscopy will be used to quantify GBM width, and urine and blood will be analyzed to determine whether the variant is protective. The results of these studies will indicate whether or not the variant has a direct impact on GBM width and severity of DN and whether modulation of GBM width should be viewed as a viable target for therapy in patients. Diabetic nephropathy is a major cause of kidney failure in the US, but there are no specific treatments to prevent it or stop its progression. Here we will test whether a change to a protein that helps form the kidney’s filtration barrier can protect from diabetic nephropathy in mice. The results of these studies could lead to new treatment strategies for human patients.
Drag a column header and drop it here to group by that column
COL4A3 Variants and Susceptibility to Diabetic Nephropathy (Miner, Jeffrey)
View Progress Report Document
No uploaded documents found.
No publications found.
No uploaded documents found.
No protocols found.
The DiaComp Steering Committee is the governing body of the consortium. The principle function of this committee is to guide the scientific direction of the consortium. This is accomplished by creating various subcommittees necessary to advance the scientific goals and providing guidance to the broader complications research community. Policies for the consortium are developed through consultation with the
External Evaluation Committee
The DiaComp Nephropathy Committee has the principal function of furthering the mission of the consortium with regard to diabetic kidney disease.
Curation Flag Information
New comment to be added:
No records to display.
Welcome to the DiaComp Login / Account Request Page.
Note: Passwords are case-sensitive.
Please save my Email Address on this machine.
Not a member?
If you are a funded DiaComp investigator, a member of an investigator's lab,
or an External Scientific Panel member to the consortium, please
request an account.
Forgot your password?
Enter your Email Address and
There was a problem with the page:
Safari Browser Detected...
We strive to make the DiaComp site compatable with as many browsers as possible, but some of our third party tools don't work with the Safari browser.
In order to explore this site we highly recommend using the most recent versions of the following browsers:
© 2018 DiaComp.org
All rights reserved
Please acknowledge all posters, manuscripts or scientific materials that were generated in part or whole using funds from the Diabetic Complications Consortium(DiaComp) using the following text:
Financial support for this work provided by the NIDDK Diabetic Complications Consortium (RRID:SCR_001415, www.diacomp.org), grants DK076169 and DK115255
Citation text and image have been copied to your clipboard. You may now paste them into your document. Thank you!